Oxidativer pulmonaler Stress  unter zytoreduktiver Therapie

T. Beinert; D. Binder; M. Stuschke; C. Oehm; R. A. Jörres; M. Schweigert; M. Seemann; H.-G. Mergenthaler; J. Behr; M. Fleischhacker; K. Possinger

doi:10.1055/s-2000-9086

Pneumologie, Inhaltsverzeichnis

Pneumologie 2000; 54(5): 201-211
DOI: 10.1055/s-2000-9086

ÜBERSICHT

Georg Thieme Verlag Stuttgart ·New York

Oxidativer pulmonaler Stress unter zytoreduktiver Therapie

T. Beinert¹ , D. Binder¹ , M. Stuschke² , C. Oehm³ , R. A. Jörres⁴ , M. Schweigert¹ , M. Seemann⁷ , H.-G Mergenthaler⁵ , J. Behr⁶ , M. Fleischhacker¹ , K. Possinger¹

¹Medizinische Klinik und Poliklinik m. S. Hämatologie und Onkologie, Charité, Campus Mitte, Berlin
²Klinik und Poliklinik für Strahlentherapie, Charité, Campus Mitte, Berlin
³Johanniter-Krankenhaus, Fachklinik für Pneumologie, Treuenbrietzen
⁴Krankenhaus Großhansdorf, Zentrum für Pneumologie und Thoraxchirurgie
⁵Medizinische Klinik für Onkologie, Katharinenhospital, Stuttgart
⁶Medizinische Klinik I, Abteilung für Pneumologie, Klinikum Großhadern, München
⁷Klinik für Radiologische Diagnostik, Universität Tübingen

Abstract

Volltext

Referenzen

Literatur

1 Jeremic B, Shibamoto Y, Acimovic L, Milisavljevic S. Hyperfractionated radiation therapy with or without concurrent low-dose daily carboplatin etoposide for stage III non-small-cell lung cancer. A randomized study. J Clin Oncol. 1996; 14 1065-1070
2 Komaki R, Scott C B, Sause W T. Induction cisplatin/vinblastine and irridation vs. irridation in unresectable squamous cell lung cancer: failure patterns by cell type in RTOG 88-08/EGOG 4588. Int J Radiat Oncol Biol Phys. 1997; 39 537-544
3 Segawa Y, Takigawa N, Kataoka M, Takata I, Fujimoto N, Ueoka H. Risk factors for development of radiation pneumonitis following radiation therapy with or without chemotherapy for lung cancer. Int J Radiat Oncol Biol Phys. 1997; 39 91-98
4 Svane G, Rotstein S, Lax I. Influence of radiation therapy on lung tissue in breast cancer patients-CT-assessed density changes 4 years after completion of radiotherapy. Acta Oncol. 1995; 34 845-849
5 Theuws J CM, Kwa S LS, Waagenar A C. Dose effect relations for early local pulmonary injury after irridation for malignant lymphoma and breast cancer. Radiother Oncol. 1998; 48 33-43
6 Einhorn L, Krause M, Hornback N. Enhanced pulmonary toxicity with bleomycin and radiotherapy in oat cell lung cancer. Cancer. 1976; 37 2414-2416
7 Ma L D, Taylor G A, Wharam M D, Wiley J M. „Recall” pneumonitis: adriamycin potentiation of radiation pneumonitis in two children. Radiology. 1993; 187 465-467
8 Trask C, Joannides T, Harper P. Radiation-induced lung fibrosis after treatment of small cell carcinoma of the lung with very high-dose cyclophosphamide. Cancer. 1985; 55 57-60
9 Halliwell B. Reactive oxygen species in living systems: source, biochemistry, and role in human disease. Am J Med. 1991; 91 (Suppl 3C) 14-22S
10 Halliwell B, Gutteridge J MC, Cross C E. Free radicals, antioxidants, and human disease: where are we now. J Lab Clin Med. 1992; 119 598-620
11 Janssen Y MW, Van Houten B, Borm P JA, Mossman B T. Cell and tissue response to oxidative damage. Lab Invest. 1993; 69 261-274
12 Poli G, Parola M. Oxidative damage and fibrogenesis. Free Radic Biol Med. 1997; 22 287-305
13 Rochester C L, Elias J A. Cytokines and cytokine networking in the pathogenesis of interstitial and fibrotic lung disorders. Sem Resp Med. 1993; 14 389-416
14 Gutteridge J MC, Mumby S, Quinlan G J, Chung K F. Pro-oxidant iron is present in human pulmonary epithelial lining fluid: implications for oxidative stress in the lung. Biochem Biophys Res Commun. 1996; 220 1024-1027
15 Zweier J L, Duke S S, Kuppusamy P, Sylvester J T, Gabrielson E W. Electron paramagnetic resonance evidence that cellular oxyen toxicity is caused by the generation of superoxide and hydroxyl free radicals. FEBS-Lett. 1989; 252 12-16
16 Gross N J. Pulmonary effects of radiation therapy. Ann Int Med. 1977; 86 81-92
17 Malik S W, Myers J L, DeRemee R A, Specks U. Lung toxicity associated with cyclophosphamide use - two distinct patterns. Am J Respir Crit Care Med. 1996; 154 1851-1856
18 Padley S, Adler B, Hansell D, Müller N. High-resolution computed tomography of drug-induced lung disease. Clin Radiol. 1992; 46 232-236
19 Abratt R P, Willcox P A. The effect of irradiation on lung function and perfusion in patients with lung cancer. Int J Radiat Oncol Biol Phys. 1995; 31 915-919
20 Marks L B, Munley M T, Bentel G C. Physical and biological predictors of changes in whole-lung function following thoracic irradiation. Int J Radiat Oncol Biol Phys. 1997; 39 563-570
21 Maasilta P, Hallman M, Taskinen E, Kivisaari L, Mattson K. Bronchoalveolar lavage fluid findings following radiotherapy for non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 1993; 26 117-123
22 White D A, Kris M G, Stover D E. Bronchoalveolar lavage cell population in bleomycin lung toxicity. Thorax. 1987; 42 551-552
23 Cooper J AD, White D A, Matthay R A. Drug-induced pulmonary disease, part 1: cytotoxic drugs. Am Rev Respir Dis. 1986; 133 321-340
24 Koh D W, Castro M. Pulmonary Toxicity of Chemotherapeutic Drugs. In: Perry, MC The Chemotherapy Sourcebook. Baltimore; Williams and Wilkins 1996: 665-695
25 Lind P ARM, Gagliardi G, Wennberg B, Fornander T. A descriptive study of pulmonary complications after postoperative radiation therapy in node-positive stage II breast cancer. Acta Oncol. 1997; 36 509-515
26 Lingos T I, Recht A, Vicini F, Abner A, Silver B, Harris J R. Radiation pneumonitis in breast cancer patients treated with conservative surgery and radiation therapy. Int J Radiat Oncol Biol Phys. 1991; 21 355-360
27 Monson J M, Stark P, Reilly J J. Clinical radiation pneumonitis and radiographic changes after thoracic radiation therapy for lung carcinoma. Cancer. 1998; 82 842-850
28 Castro M, Veeder M H, Mailliard J A, Tazelaar H D, Jett J R. A prospective study of pulmonary function in patients receiving mitomycin. Chest. 1996; 109 939-944
29 Pavlakis N, Bell D R, Millward M J, Levi J A. Fatal pulmonary toxicity resulting from treatment with gemcitabine. Cancer. 1997; 80 286-291
30 Simpson A B, Paul J, Graham J, Kaye S B. Fatal bleomycin pulmonary toxicity in the west of Scotland 1991 - 95: a review of patients with germ cell tumours. Br J Cancer. 1998; 78 1061-1066
31 Morgan G W, Breit S N. Radiation and the lung: a reevaluation of the mechanisms mediating pulmonary injury. Int J Radiat Oncol Biol Phys. 1995; 31 361-369
32 Gibson P G, Bryant D H, Morgan G W. Radiation-induced lung injury: a hypersensitivity pneumonitis?. Ann Int Med. 1988; 109 288-291
33 Vujaskovic Z, Down J D, van t'Veld A A. Radiological and functional assessment of radiation-induced lung injury in the rat. Exp Lung Res. 1998; 24 137-148
34 Schnabel A, Richter C, Bauerfeind S, Gross W L. Bronchoalveolar lavage cell profile in methotrexate induced pneumonitis. Thorax. 1997; 52 377-379
35 Mark G J, Lehimgar-Zadeh A, Ragsdale B D. Cyclophosphamide pneumonitis. Thorax. 1978; 33 89-94
36 Tucker A S, Newman A J, Alvorado C. Pulmonary pleural and thoracic changes complicating chemotherapy. Radiology. 1977; 125 805
37 Crouch E. Pathobiology of pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol. 1990; 259 L159-L184
38 Reed C R, Glauser F L. Drug-induced noncardiogenic pulmonary edema. Chest. 1991; 100 1120-1124
39 Beinert T, Binder D, Oehm C. Increased levels of vascular endothelial growth factor in bronchoalveolar lavage of patients with bronchial carcinoma-effect of tumour activity and oxidative stress due to radio-chemotherapy. Eur J Med Res. 1999; 4 328-334
40 Rubin P, Johnston C J, Williams J P, McDonald S, Finkelstein J N. A perpetual cascade of cytokines postirradiation leads to pulmonary fibrosis. Int J Radiat Oncol Biol Phys. 1995; 33 99-109
41 Sage H, Farin F M, Striker G E, Fisher A B. Granular pneumocytes in primary culture secrete several major components of the extracellular matrix. Biochemistry. 1983; 22 2148-2155
42 Vergara J A, Raymond U, Thet L A. Changes in lung morphology and cell number in radiation pneumonitis and fibrosis: a quantitative ultrastructural study. Int J Radiat Oncol Biol Phys. 1987; 13 723-732
43 Hunninghake G W, Gadek J E, Kawanami O, Ferrans V J, Crystal R G. Inflammatory and immune processes in the human lung in health and disease: Evaluation by bronchoalveolar lavage. Am J Pathol. 1979; 97 149-206
44 Geara F B, Komaki R, Tucker S L, Travis E L, Cox J D. Factors influencing the development of lung fibrosis after chemoradiation for small cell carcinoma of the lung: Evidence for inherent interindividual variation. Int J Radiat Oncol Biol Phys. 1998; 41 279-286
45 Johnston C J, Stripp B R, Piedbeouf B. Inflammatory and epithelial responses in mouse strains that differ in sensitivity to hyperoxic injury. Exp Lung Res. 1998; 24 189-202
46 Barquinero J F, Barrois L, Caballin M R. Occupational exposure to radiation induces an adaptive response in human lymphocytes. Int J Radiat Biol. 1995; 67 187-191
47 Youngblom J H, Wiencke J K, Wolff S. Inhibition of the adaptive response of human lymphocytes to very low doses of ionizing radiation by the protein synthesis inhibitor cycloheximide. Mutat Res. 1989; 227 257-261
48 Cohen D S, Palmer E, Welch W J, Sheppard D. The response of guinea pig airway epithelial cells and alveolar macrophages to environmental stress. Am J Respir Cell Mol Biol. 1991; 5 133-143
49 Deitch E A, Beck S C, Cruz N C, De Maio A. Induction of heat shock gene expression in colonic epithelial cells after incubation with Escherichia coli or endotoxin. Crit Care Med. 1995; 23 1371-1376
50 Javadpour M, Kelly C J, Chen G, Stokes K, Leahy A, Bouchier-Hayes D J. Thermotolerance induces heat shock protein 72 expression and protects against ischaemia-reperfusion-induced lung injury. Br J Surg. 1998; 85 943-946
51 Jornot L, Mirault M E, Junod A F. Differential expression of hsp70 stress points in human endothelial cells exposed to heat shock and hydrogen peroxide. Am J Respir Cell Mol Biol. 1991; 5 265-275
52 Polla B S, Kantengwa S, Francois D. Mitochondria are selective targets for the protective effects of heat shock against oxidative injury. Proc Natl Acad Sci USA. 1996; 93 6458-6463
53 Ikushima T, Aritomi H, Morisita J. Radioadaptive response: efficient repair or radiation-induced DNA damage in adapted cells. Mutat Res Fundam Mol Mech Mutagen. 1996; 358 193-198
54 Ho Y S, Dey M S, Crapo J D. Antioxidant enzyme expression in rat lungs during hyperoxia. Am J Physiol. 1996; 270 L810-L818
55 Preville X, Salvemini F, Giraud S. Mammalian small stress proteins protect against oxidative stress through their ability to increase glucose-6-phosphate dehydrogenase activity and by maintaining optimal cellular detoxifying machinery. Exp Cell Res. 1999; 247 61-78
56 Gorman A M, Heavey B, Creagh E, Cotter T G, Samali A. Antioxidant-mediated inhibition of the heat shock response leads to apoptosis. FEBS-Lett. 1999; 445 98-102
57 Park Y M, Han M Y, Blackburn R V, Lee Y L. Overexpression of HSP25 reduces the level of TNFalpha-induced oxidative damage biomarker, 8-hydroxy-2′deoxyguanosine, in L929 cells. J Cell Physiol. 1998; 174 27-34
58 Wong H R, Menendez I Y, Ryan M A, Denenberg A G, Wispe J R. Increased expression of heat shock protein-70 protects A549 cells against hyperoxia. Am J Physiol Lung Cell Mol Physiol. 1998; 275 L836-L841
59 Satoh M, Hirayoshi K, Yokota S I, Hosokawa N, Nagata K. Intracellular interaction of collagen-specific stress protein HSP47 with newly synthesized procollagen. J Cell Biol. 1996; 133 469-483
60 Nagata K, Saga S, Yamada K M. A major collagen-binding protein of chick embryo fibroblasts is a novel heat shock protein. J Cell Biol. 1986; 103 223-229
61 Razzaque M S, Hossain M A, Kohno S, Taguchi T. Bleomycin-induced pulmonary fibrosis in rat is associated with increased expression of collagen-binding heat shock protein (HSP) 47. Virchows Arch. 1998; 432 455-460
62 Sunamoto M, Kuze K, Tsuji H. Antisense oligonucleotides against collagen-binding stress protein HSP47 suppress collagen accumulation in experimental glomerulonephritis. Lab Invest. 1998; 78 967-972
63 Bonay M, Soler P, Riquet M, Battesti J P, Hance A J, Tazi A. Expression of heat shock proteins in human lung and lung cancer. Am J Respir Cell Mol Biol. 1994; 10 453-461
64 Spitz D R, Dewey W C, Li G C. Hydrogen peroxide or heat shock induces resistance to hydrogen peroxide in chinese hamster fibroblasts. J Cell Physiol. 1987; 131 364-373
65 Wong H R, Mannix R J, Rusnak J M. The heat shock response attenuates lipopolysaccaride-mediated apoptosis in cultured sheep pulmonary artery endothelial cells. Am J Respir Cell Mol Biol. 1996; 15 745-751
66 Hamilton R FJ, Hazbun M E, Jumper C A, Eschenbacher W L, Holian A. 4-hydroxynonenal mimics ozone-induced modulation of macrophage function ex vivo. Am J Respir Cell Mol Biol. 1996; 15 275-282
67 Kindas-Mugge I, Pohl W R, Zavadova E. Alveolar macrophages of patients with adult respiratory distress syndrome express high levels of heat shock protein 72 mRNA. Shock. 1996; 5 184-189
68 Vignola A M, Chanez P, Polla B S, Vic P, Godard P, Bousquet J. Increased expression of heat shock protein 70 on airway cells in asthma and chronic bronchitis. Am J Respir Cell Mol Biol. 1995; 13 683-691
69 Thrall R S, Barton R W, D'Amato D A, Sulavik S B. Differential cellular analysis of bronchoalveolar lavage fluid obtained at various stages during the development of bleomycin-induced pulmonary fibrosis in the rat. Am Rev Respir Dis. 1982; 126 488-492
70 Travis E L, Harley R A, Fenn J O, Klobukowski C J, Hargrove H B. Pathologic changes in the lung following single and multi-fraction irradiation. Int J Radiat Oncol Biol Phys. 1977; 2 475-490
71 Ward H E, Kemsley L, Davies L, Holecek M, Berend N. The pulmonary response to sublethal thoracic irradiation in the rat. Radiat Res. 1993; 136 15-21
72 Aso Y, Yoneda K, Kikkawa Y. Morphological and biochemical study of pulmonary changes induced by bleomycin in mice. Lab Invest. 1976; 35 558-568
73 Jones A W, Reeve N L. Ultrastructural study of bleomycin-induced pulmonary changes in mice. J Pathol. 1978; 124 227-233
74 Guerry-Force M L, Perkett E A, Brigham K L, Meyrick B. Early structural changes in sheep lung following thoracic irradiation. Radiat Res. 1988; 114 138-153
75 Barnett D. Preclinical toxicology of ifosfamide. Semin Oncol. 1982; 9 (Suppl 1) 8-13
76 Fahey P J, Utell M J, Mayewski R J, Wandtke J D, Hyde R W. Early diagnosis of bleomycin pulmonary toxicity using bronchoalveolar lavage in dogs. Am Rev Respir Dis. 1982; 126 126-130
77 Hay J, Shahzeide S, Laurent G. Mechanisms of bleomycin-induced lung damage. Arch Toxicol. 1991; 65 81-94
78 Kanofsky J R. Singlet oxygen production by bleomycin. J Biol Chem. 1986; 261 13-546 - 13 550
79 Slosman D O, Costabella P M, Roth M, Werlen G, Polla B S. Bleomycin primes monocytes-macrophages for superoxide production. Eur Respir J. 1990; 3 772-778
80 Scheule R K, Perkins R C, Hamilton R, Holian A. Bleomycin stimulation of cytokine secretion by the human alveolar macrophage. Am J Physiol Lung Cell Mol Physiol. 1992; 262 L386-L391
81 Colvin M. The comparative pharmacology of cyclophosphamide and ifosfamide. Semin Oncol. 1982; 9 (Suppl. 1) 2-7
82 Gurtoo H L, Hipkens J H, Sharma S D. Role of glutathione in the metabolism-dependent toxicity and chemotherapy of cyclophosphamide. Cancer Res. 1981; 41 3584-3591
83 Patel J M, Block E R. Cyclophosphamide-induced depression of the antioxidant defense machanisms of the lung. Exp Lung Res. 1985; 8 153-165
84 Issels R D, Meier T H, Müller E, Multhoff G, Wilmanns W. Ifosfamide induced stress response in human lymphocytes. Molec Aspects Med. 1993; 14 281-286
85 Sinha B K, Politi P M. Anthracyclines. Cancer Chemoth Biol Modif. 1990; 11 45-57
86 Gianni L, Vigano Lanzi L, Niggellar M, Malatesta V. Role of daunosamine and hydroxyacetyl side chain in reaction with iron and lipid peroxidation by anthracyclines. J Natl Cancer Inst. 1988; 80 1104-1111
87 Gille L, Nohl H. Analyses of the molecular mechanism of adriamycin-induced cardiotoxicity. Free Radic Biol Med. 1997; 23 775-782
88 Krishna M C, DeGraff W, Tamura S. Mechanisms of hypoxic and aerobic cytotoxicity of mitomycin C in chinese hamster V79 cells. Cancer Res. 1991; 51 6622-6628
89 Murrell G AC, Francis M JO, Bromley L. Modulation of fibroblast proliferation by oxygen free radicals. Biochem J. 1990; 265 659-665
90 Fuks Z, Persaud R S, Alfieri A. Basic fibroblast growth factor protects endothelial cells against radiation-induced programmed cell death in vitro and in vivo. Cancer Res. 1994; 54 2582-2590
91 Cochrane C G. Mechanisms of oxidant injury of cells. Molec Aspects Med. 1991; 12 137-147
92 Lelli J L, Becks L L, Dabrowska M I, Hinshaw D B. ATP converts necrosis to apoptosis in oxidant-injured endothelial cells. Free Radic Biol Med. 1998; 25 694-702
93 Roitt I M, Brostoff J, Male D K. Kurzes Lehrbuch der Immunologie. Stuttgart, New York; Georg Thieme Verlag 1991: 79-114
94 Elias J A, Schreiber A D, Gustilo K. Differential interleukin-1 elaboration by unfractionated and density fractionated human alveolar macrophages and blood monocytes: relationship to cell maturity. J Immunol. 1985; 135 2198-2204
95 Weswers M D, Herzyk D J. Alveolar macrophages differ from blood monocytes in human IL-1 beta release. Quantitation by enzyme-linked immunoassay. J Immunol. 1989; 143 1635-1641
96 O'Brien-Ladner A, Nelson M E, Kimler B F, Wesselius L J. Release of interleukin-1 by human alveolar macrophages after in vitro irradiation. Radiat Res. 1993; 136 37-41
97 Parola M, Pinzani M, Casini A. Stimulation of lipid peroxidation or 4-hydroxynonenal treatment increases procollagen alpha (I) gene expression and synthesis in human liver fat storing cells. Biochem Biophys Res Commun. 1993; 194 1044-1050
98 Curzio M. Interaction between neutrophils and 4-hydroxyalkenals and consequences on neutrophil motility. Free Radic Res Commun. 1988; 5 55-66
99 Curzio M, Esterbauer H, Dianzani M U. Chemotactic acitivty of hydroxyalkenals on rat neutrophils. Int J Tissue React. 1985; 7 137-142
100 Schreck R, Rieber P, Baeuerle P A. Reactive oxygen intermediates as apparently widely used messengers in the acitvation of NF-kappa B transcription factor and HIV-1. EMBO Journal. 1991; 10 2247-2258
101 Datta R, Hallahan D E, Kharbanda S M. Involvement of reactive oxygen intermediates in the induction of c-jun gene transcription by ionising radiation. Biochemistry. 1992; 31 8300-8306
102 Tischer E, Mitchell R, Hartman T. The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J Biol Chem. 1991; 266 11-947 - 11 954
103 Messer G, Weiss E H, Baeuerle P A. Tumor necrosis factor beta (TNF-beta) induces binding to the NF-kappa B transcription factor to a high-affinity kappa B element in the TNF-beta promoter. Cytokine. 1990; 2 1-9
104 Libermann T A, Baltimore D. Acitvation of the interleukin-6 gene expression through the NF-kappa B transcription factor. Mol Cell Biol. 1990; 10 2327-2334
105 Kim S J, Dehnez F, Kim K Y, Holt J T, Sporn M B, Roberts A B. Acitvation of the second promoter of the transforming growth factor-beta1 gene by transforming growth factor-beta1 and phorbol ester occurs through the same target sequences. J Biol Chem. 1989; 264 19-373 - 19 378
106 Lin X, Wang Z, Gu L, Deuel T F. Functional analysis of the human platelet-derived growth factor A-chain promoter region. J Biol Chem. 1992; 267 25-614 - 25 619
107 Bonizzi G, Dejardin E, Piret B, Piette J, Merville M P, Bours V. Interleukin-1 induces nuclear factor kappaB in epithelial cells independently of the production of reactive oxygen intermediates. Eur J Biochem. 1996; 242 544-549
108 Duckett C S, Perkins N D, Leung K, Agranoff A B, Nabel G J. Cytokine induction of nuclear factor kappaB in cycling and growth-arrested cells. Evidence for cell cycle-independent activation. J Biol Chem. 1995; 270 18-836 - 18 840
109 Staal F JJ, Roederer M, Herzenberg L A. Intracellular thiols regulate the activation of nuclear factor Kappa B and transcription of human immunodeficiency virus. Proc Natl Acad Sci USA. 1990; 87 9943-9949
110 Burdon R H. Superoxide and hydrogen peroxide in relation to mammalian cell proliferation. Free Radic Biol Med. 1995; 18 775-794
111 Babior B M. Oxygen-dependent microbial killing by phagocytes. N Engl J Med. 1978; 298 659-668
112 Weiss S S. Tissue destruction by neutrophils. N Engl J Med. 1989; 320 365-376
113 Behr J. Interstitielle Lungenerkrankungen und Oxidanzienbelastung. Pathogenetisches Bindeglied zwischen Alveolitis und Fibroblastenstimulation. Fortschr Med. 1998; 116 41-42
114 Fox R B, Hoidal J R, Brown D M, Repine J E. Pulmonary inflammation due to oxygen toxicity: involvement of chemotactic factors and polymorphonuclear leukocytes. Am Rev Respir Dis. 1981; 123 521-523
115 Biemond P, Van Eijk H G, Swaak A JG, Koster J F. Iron mobilization from ferritin by superoxide derived from stimulated polymorphonuclear leukocytes: Possible mechanisms in inflammation disease. J Clin Invest. 1984; 73 1576-1579
116 Gutteridge J MC. Iron promoters of the Fenton reaction and lipid peroxidation can be released from haemoglobin by peroxides. FEBS-Lett. 1986; 201 291-295
117 Gorbunov N V, Elsayed N M, Kisin E R, Kozlov A V, Kagan V E. Air blast-induced pulmonary oxidativ stress: Interplay among hemoglobin, antioxidants, and lipid peroxidation. Am J Physiol Lung Cell Mol Physiol. 1997; 272 L320-L334
118 Prober J S, Bevilacqua M P, Mendrick D C, Lapierre L A, Fiers W, Gimbrone J. Two distinct monokines, interleukin 1 and tumour necrosis factor, each independently induce biosynthesis and transient expression of the same antigen on the surface of cultured human vascular endothelial cells. J Immunol. 1986; 136 1680-1687
119 Meier B, Radeke H H, Selle S. Human fibroblasts release active oxygen species in response to interleukin-1 and tumour necrosis factor. Biochem J. 1989; 263 539-545
120 Friedl H P, Till G O, Ryan U S, Ward P A. Mediator-induced activation of xanthine oxidase in endothelial cells. FASEB J. 1989; 3 2512-2518
121 Phan S H, Gannon D E, Varani J, Ryan U S, Ward P A. Xanthine oxidase acticity in rat pulmonary artery endothelial cells and its alterations by activated neutrophils. Am J Pathol. 1989; 134 1201-1211
122 Halliwell B. Antioxidants and human disease: a general introduction. Nutr Rev. 1997; 55 44-49
123 Unemori E N, Bouhana K S, Werb Z. Vectorial secretion of extracellular matrix proteins, matrix-degrading proteinases, and tissue inhibitor of metalloproteinase by endothelial cells. J Biol Chem. 1990; 265 445-451
124 Elias J A, Zitnik R, Ray P. Fibroblast immune-effector function. In: Phipps, R Pulmonary fibroblast heterogeneity. Boca Raton; CRC Press 1992: 295-322
125 Burdon R H, Rice-Evans C. Free radicals and the regulation of mammalian cell proliferation. Free Radic Res Commun. 1989; 6 345-358
126 Travis E L, Down J D. Repair in mouse lung after split doses of X rays. Radiat Res. 1981; 87 166-174
127 Franko A J, Sharplin J. Development of fibrosis after lung irridation in relation to inflammation and lung function in a mouse strain prone to fibrosis. Radiat Res. 1994; 140 347-355
128 Rubin P, Finkelstein J, Shapiro D. Molecular biology mechanisms in the radiation induction of pulmonary injury syndromes: interrelationship between the alveolar macrophage and the septal fibroblast. Int J Radiat Oncol Biol Phys. 1992; 24 93-101
129 Piguet P F, Kaufman S, Barazzone C, Muller M, Ryffel B, Eugster H P. Resistance of TNF/LT alpha double deficient mice to bleomycin-induced fibrosis. Int J Exp Pathol. 1997; 78 43-48
130 Thrall R S, Vogel S N, Evans R, Shultz L D. Role of tumor necrosis factor-α in the spontenaeous development of pulmonary fibrosis in viable motheaten mutant mice. Am J Pathol. 1997; 151 1303-1310

T. Beinert

Medizinische Klinik und Poliklinik m.S. Hämatologie und Onkologie

CharitÉ, Campus Mitte

10115 Berlin